ArticleJournal of neurology2025
Pseudobulbar affect: clinical associations, social impact and quality of life implications - Lessons from PLS.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Early Cognitive and Behavioral Changes in Primary Lateral Sclerosis: A Population-Based Study.European journal of neurology · 2026Article
- Exploring the Lived Experiences of Individuals with Amyotrophic Lateral Sclerosis (ALS): A Qualitative Study and Conceptual Model of Signs, Symptoms, and Functional Impacts.Neurology and therapy · 2026Article
- Driving with Motor Neuron Disease: Disease-Specific Considerations, Multi-Domain Assessments and Support Strategies.Brain sciences · 2026Review
- Pseudobulbar Affect: A Network Disorder Linking Emotion, Neurobiology, and Therapeutics.Cureus · 2025Review
- New developments in imaging in ALS.Journal of neurology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPseudobulbar affect (PBA) is a well-recognised and troublesome clinical phenomenon in a range of neuroinflammatory, neoplastic, neurovascular and neurodegenerative conditions. It is often under-recognised in the community, frequently mistaken for psychiatric manifestations, appropriate pharmacological treatment is often delayed, and may result in a sense of embarrassment or lead to social isolation. Despite its considerable quality of life (QoL) implications and the challenges associated with its effective management, it is notoriously understudied.
methodsAs the incidence of PBA is lower in non-motor neuron disease patient cohorts, and the social and QoL impact of PBA is not sufficiently recognised, a purpose-designed study was conducted in a Primary Lateral Sclerosis (PLS) cohort to assess the clinical correlates and social impact of PBA.
resultsPBA was very strongly associated with pseudo-bulbar motor dysfunction. Dysphagia (OR 14, P = .005) and the presence of abnormal jaw jerk (OR 19.8, P < 0.001) greatly increased odds of PBA. There was no significant difference in the cognitive or behavioural profiles between those with PBA and those without it. Poorly controlled laughing (85%) was more prevalent than crying (69%) among PLS patients with PBA. No individual experienced PBA symptoms prior to the motor manifestations of PLS. Most patients were unaware that PBA was common in their neurological condition. The mean PBA Impact score was 5 (range 1-17) and correlated with CNS-LS crying subscores (r = .693, p = .006). DISCUSSION: The severity of pseudobulbar affect correlates with motor manifestations of pseudobulbar palsy, a link supporting emerging imaging studies regarding bilateral corticobulbar tract degeneration as in important aetiological factor. The social and quality of life ramifications of pseudobulbar affect can be readily demonstrated by purpose-designed questionnaires.
conclusionsDespite sporadic reports, the clinical, social, caregiver burden and quality of life implications of pseudobulbar affect remain poorly characterised. The comprehensive evaluation of the clinical correlates of PBA helps to elucidate the underlying pathophysiology. Ultimately, the comprehensive assessment of both the aetiology and social impact of PBA helps to raise awareness of this entity, reduce misdiagnoses, enhance the early recognition of this phenomenon and encourage proactive pharmacological intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.